REXTOL 5 mcg/ml

Treatment of secondary hyperparathyroidism (HPT)

THERAPEUTIC INDICATIONS

Prevetion and treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) who are on haemodialysis. 

Rextol 5 mcg/ml
• Each 1 ml ampoule contains 5 micrograms of paricalcitol.
• Each 2 ml ampoule contains 10 micrograms of paricalcitol.

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.